Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Phuong H. D. Nguyen, Siming Ma, Cheryl Zi Jin Phua, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 293
Tissue‐derived extracellular vesicles in cancers and non‐cancer diseases: Present and future
Su‐Ran Li, Qi‐Wen Man, Xin Gao, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 14
Open Access | Times Cited: 149
Mechanisms of drug resistance in HCC
Alexandra D. Ladd, Sergio Duarte, İlyas Şahin, et al.
Hepatology (2023)
Closed Access | Times Cited: 149
Unsupervised spatially embedded deep representation of spatial transcriptomics
Hang Xu, Huazhu Fu, Yahui Long, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 128
Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC
Sheena Suthen, Chun Jye Lim, Phuong H. D. Nguyen, et al.
Hepatology (2022) Vol. 76, Iss. 5, pp. 1329-1344
Open Access | Times Cited: 115
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 99
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yun‐Fan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 135-156.e17
Closed Access | Times Cited: 51
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 8
Immunotherapy: an alternative promising therapeutic approach against cancers
Sneh Lata Gupta, Srijani Basu, Vijay Soni, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9903-9913
Open Access | Times Cited: 65
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Wantao Wu, Yihan Liu, Shan Zeng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
Wenhao Xu, Yuhao Wu, Wangrui Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 4884-4900
Open Access | Times Cited: 56
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
Phuong H. D. Nguyen, Martin Wasser, Chong Teik Tan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Towards a consensus definition of immune exclusion in cancer
Ankur Tiwari, Tamás Oravecz, Laura A. L. Dillon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 25
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
New roles of tumor-derived exosomes in tumor microenvironment
Shiqian Chen, Jinzhe Sun, Huan Zhou, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 151-166
Open Access | Times Cited: 12
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Spatial Transcriptome‐Wide Profiling of Small Cell Lung Cancer Reveals Intra‐Tumoral Molecular and Subtype Heterogeneity
Zicheng Zhang, Xujie Sun, Yutao Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 9
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma
Keerthi Kurma, Olivier Manches, Florent Chuffart, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4981-4981
Open Access | Times Cited: 52
IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
Xiao Xiang, Ziyang Liu, Chong Zhang, et al.
Advanced Science (2021) Vol. 8, Iss. 17
Open Access | Times Cited: 47
Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment
Yue-fan Wang, Shengxian Yuan, Hui Jiang, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4163-4180
Open Access | Times Cited: 38
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
Danyang Li, Yingcheng Yao, Yuhan Rao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 34
γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 7
Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate
Priyanka Hirani, Jacqueline McDermott, Vinothini Rajeeve, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 970-985
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top